Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Confluent, Inc. Director's Dealing 2023

Jun 2, 2023

30829_dirs_2023-06-01_efdbdb8e-bdda-4752-8af2-fdac311c3787.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Confluent, Inc. (CFLT)
CIK: 0001699838
Period of Report: 2023-05-30

Reporting Person: Tomlinson Steffan (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-05-30 Class A Common Stock C 66667 Acquired 380338 Direct
2023-05-30 Class A Common Stock S 66667 $30.05 Disposed 313671 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-05-30 Stock Option (Right to Buy) $6.65 M 66667 Disposed 2030-08-05 Class B Common Stock (66667) Direct
2023-05-30 Class B Common Stock $ C 66667 Acquired Class A Common Stock (66667) Direct
2023-05-30 Class B Common Stock $ C 66667 Disposed Class A Common Stock (66667) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Class B Common Stock $ Class A Common Stock (150425) 150425 Indirect

Footnotes

F1: Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.

F2: Shares sold pursuant to a 10b5-1 trading plan.

F3: The shares were sold at prices ranging from $30.00 to $30.43. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The shares subject to the option are immediately exercisable. 25% of the shares vested on June 15, 2021 and the remainder vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.